EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum IL-17 and TNFα as prognostic biomarkers in systemic sclerosis patients: a prospective study

Joanna Kosałka-Węgiel iD, Sabina Lichołai iD, Renata Pacholczak-Madej iD, Sylwia Dziedzina iD, Mamert Milewski, Piotr Kuszmiersz iD, Anna Korona iD, Jolanta Gąsior, Aleksandra Matyja-Bednarczyk iD, Helena Kwiatkowska, Lech Zaręba iD, Andżelika Siwiec-Koźlik iD und 7 weitere

Rheumatology International · 2023

DOI: 10.1007/s00296-023-05499-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rheumatology International, 2023. Verfasst von Joanna Kosałka-Węgiel und 18 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology and Immunology Clinical Department, University Hospital, Krakow, Poland. joanna.kosalka@uj.edu.pl. Hauptthemen laut MEDLINE: Lung Neoplasms, Scleroderma, Systemic. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerstwo Edukacji i Nauki.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent reports have demonstrated that endothelial injury is critical in the pathogenesis of systemic sclerosis (SSc) and is associated with increased levels of circulating inflammatory biomarkers. This study aims to analyze the serum concentrations of selected cytokines and evaluate their relationship with SSc clinics and the long-term course of the disease. This study included 43 SSc patients and 24 matched healthy controls. In both groups, we measured serum levels of inflammatory cytokines related to the inflammatory response, such as tumor necrosis factor (TNF)α, interferon (IFN)γ, interleukin (IL)-4, IL-6, IL-10, and IL-17, and fibroblast activation protein (FAP). Additionally, in SSc patients, we evaluated the presence of four single nucleotide polymorphisms (SNPs) located in the promotor region of the TNFA gene, namely rs361525, rs1800629, rs1799964, and rs1799724, which might be related to increased TNFα concentrations. The main aim consisted of associating inflammatory cytokines with (1) clinical disease characteristics and (2) longitudinal observation of survival and cancer prevalence. SSc patients were characterized by a 17% increase in serum TNFα. There was no other difference in serum cytokines between the studied groups and diffuse vs. limited SSc patients. As expected, evaluated serum cytokines correlated with inflammatory biomarkers (e.g., IL-6 and C-reactive protein). Interestingly, patients with higher IL-17 had decreased left ventricle ejection fraction. During the median 5-year follow-up, we recorded four cases of neoplastic diseases (lung cancer in two cases, squamous cell carcinoma of unknown origin, and breast cancer with concomitant multiple myeloma) and nine deaths. The causes of death included lung cancer ( n = 2), renal crisis ( n = 1), multiple-organ failure ( n = 1), and unknown reasons in five cases. Surprisingly, higher TNFα was associated with an increased cancer prevalence, while elevated IL-17 with death risk in the follow-up. Furthermore, the AG rs361525 genotype referred to higher TNFα levels than GG carriers. Both AG rs361525 and CT rs1799964 genotypes were associated with increased cancer risk. Higher serum concentrations of TNFα characterize the SSc patients, with the highest values associated with cancer. On the other hand, increased IL-17 in peripheral blood might predict poor SSc prognosis. Further research is needed to validate these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsScleroderma, SystemicHumansBiomarkersCytokinesInterleukin-17Interleukin-6PrognosisProspective StudiesTumor Necrosis Factor-alpha

Stichwörter der Autor:innen

BiomarkersCancerCytokinesInterleukin 17Systemic sclerosisTumor necrosis factor-alpha

Substanzen

BiomarkersCytokinesInterleukin-17Interleukin-6Tumor Necrosis Factor-alphaTNF protein, humanIL17A protein, human

Autor:innen und Institutionen

  • Rheumatology and Immunology Clinical Department, University Hospital, Krakow, Poland. joanna.kosalka@uj.edu.pl.
  • Department of Rheumatology and Immunology, Jagiellonian University Medical College, Jakubowskiego 2 Str., 30-688, Kraków, Poland. joanna.kosalka@uj.edu.pl.
  • 2nd Department of Internal Medicine, Jagiellonian University Medical College, Jakubowskiego 2 Str., 30-688, Kraków, Poland. joanna.kosalka@uj.edu.pl.
  • 2nd Department of Internal Medicine, Jagiellonian University Medical College, Jakubowskiego 2 Str., 30-688, Kraków, Poland.
  • Department of Chemotherapy, The District Hospital, Sucha Beskidzka, Poland.
  • Department of Anatomy, Jagiellonian University Medical College, Krakow, Poland.

ORCID-Profile: Joanna Kosałka-Węgiel, Sabina Lichołai, Renata Pacholczak-Madej, Sylwia Dziedzina, Piotr Kuszmiersz, Anna Korona, Aleksandra Matyja-Bednarczyk, Lech Zaręba, Andżelika Siwiec-Koźlik, Paweł Koźlik-Siwiec, Weronika Pociej-Marciak, Marek Sanak, Jacek Musiał, Stanisława Bazan-Socha, Mariusz Korkosz

Förderung

  • Ministerstwo Edukacji i Nauki

Zitieren

APA

Kosałka-Węgiel, J., Lichołai, S., Pacholczak-Madej, R., Dziedzina, S., Milewski, M., Kuszmiersz, P., Korona, A., Gąsior, J., Matyja-Bednarczyk, A., Kwiatkowska, H., Zaręba, L., Siwiec-Koźlik, A., Koźlik-Siwiec, P., Wach, A., Pociej-Marciak, W., Sanak, M., Musiał, J., Bazan-Socha, S., & Korkosz, M. (2023). Serum IL-17 and TNFα as prognostic biomarkers in systemic sclerosis patients: a prospective study. Rheumatology International. https://doi.org/10.1007/s00296-023-05499-9

Vancouver

Kosałka-Węgiel J, Lichołai S, Pacholczak-Madej R, Dziedzina S, Milewski M, Kuszmiersz P, et al. Serum IL-17 and TNFα as prognostic biomarkers in systemic sclerosis patients: a prospective study. Rheumatology International. 2023. doi:10.1007/s00296-023-05499-9

BibTeX
@article{KosakaWgiel2023,
  author = {Kosałka-Węgiel, Joanna and Lichołai, Sabina and Pacholczak-Madej, Renata and Dziedzina, Sylwia and Milewski, Mamert and Kuszmiersz, Piotr and Korona, Anna and Gąsior, Jolanta and Matyja-Bednarczyk, Aleksandra and Kwiatkowska, Helena and Zaręba, Lech and Siwiec-Koźlik, Andżelika and Koźlik-Siwiec, Paweł and Wach, Anita and Pociej-Marciak, Weronika and Sanak, Marek and Musiał, Jacek and Bazan-Socha, Stanisława and Korkosz, Mariusz},
  title = {Serum IL-17 and TNFα as prognostic biomarkers in systemic sclerosis patients: a prospective study},
  journal = {Rheumatology International},
  year = {2023},
  doi = {10.1007/s00296-023-05499-9}
}
Kostenlos starten →